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Obesity is considered a chronic low-grade inﬂammatory state associated with a chronic oxidative stress
caused by superoxide production (O2 ). The superoxide dismutase manganese dependent (SOD2) cata-
lyzes O2 in H2O2 into mitochondria and is encoded by a single gene that presents a common polymor-
phism that results in the replacement of alanine (A) with a valine (V) in the 16 codon. This
polymorphism has been implicated in a decreased efﬁciency of SOD2 transport into targeted mitochon-
dria in V allele carriers. Previous studies described an association between VV genotype and metabolic
diseases, including obesity and diabetes. However, the causal mechanisms to explain this association
need to be more elucidated. We postulated that the polymorphism could inﬂuence the inﬂammatory
response. To test our hypothesis, we evaluated the in vitro cytokines production by human peripheral
blood mononuclear cells (PBMCs) carrier’s different Ala16Val-SOD2 genotypes (IL-1, IL-6, IL-10, TNF-a,
IFN-c). Additionally, we evaluated if the culture medium glucose, enriched insulin, could inﬂuence the
cytokine production. Higher levels of proinﬂammatory cytokines were observed in VV-PBMCs when com-
pared to AA-PBMCs. However, the culture medium glucose and enriched insulin did not affect cytokine
production. The results suggest that Ala16Val-SOD2 gene polymorphism could trigger the PBMCs proin-
ﬂammatory cytokines level. However, discerning if a similar mechanism occurs in fat cells is an open
question.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Chronic diseases such as obesity, type II diabetes and athero-
sclerosis are related to a chronic inﬂammatory state; the imbalance
of inﬂammatory cytokines can affect cellular function [1]. ROS are
capable of interfering with various redox-sensitive intracellular
signal transduction cascades and regulating the expression of overolecular Aspects Associated
atarina, Av. Oiapoc, 211, São
49 36311075; fax: +55 49
.
er OA license.200 genes that lead, among other things, to the production of pro-
inﬂammatory cytokines [2–4]. The superoxide radical is an impor-
tant ROS constantly produced by the human metabolism; the level
of this molecule is controlled by superoxide dismutase enzymes.
The superoxide dismutase manganese dependent (SOD2 or
MnSOD) activity occurs just into mitochondria whereas the other
SODs (Cu/Zn dependent) present activity in cytosol and extracellu-
lar matrix.
MnSOD dismutate the O2 to H2O2, which is then converted to
non-toxic H2O and O2 by glutathione peroxidase (GPX1) and cata-
lase enzymes [5]. The human MnSOD gene presents a polymor-
phism localized in an exon 2 Val16Ala variation (rs 4880) that
results in a valine to alanine substitution, causing a conformational
change from a b-sheet to an a-helix, inducing a 30–40% increase in
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has been reported to increase the risk of oxidative stress-related
pathological conditions related to both homozygous genotypes
(AA and VV) due a MnSOD imbalance. The V allele presents higher
superoxide radical levels than the A allele due its lower efﬁciency
to dismutate this molecule into H2O2 [6].
The VV genotype has been related to metabolic disorders and
their complications such as diabetes or diabetic cardiovascular dis-
eases [7,8], and diabetic nephropathy [9], retinopathy [10]an in-
crease in plasmatic oxided-LDL levels [11] and in oxidative stress
biomarkers, mainly in hypercholesterolemic patients [12]. An asso-
ciation between the VV genotype and obesity [13] was also ob-
served in a previous study. A complementary in vitro study
showed that when activated by phytohaemagglutinin (PHA), the
T-cell carrier VV genotype presented lower viability and higher li-
pid peroxidation levels when compared to AA T-cells [14].
These results showed a potential inﬂuence of Ala16Val–MnSOD
polymorphism on inﬂammatory immune response corroborating
previous evidences that suggested SOD2 role on inﬂammation re-
sponse [15]. Therefore, we hypothesized that a MnSOD imbalance
could affect the in vitro lymphocyte proinﬂammatory cytokines
production by PBMCs carriers, different Ala16Val–MnSOD geno-
types in a regular culture medium, and a glucose and insulin-en-
riched culture medium. These treatments were performed
because the PBMCs of metabolic disorders, such as those found
in obese and diabetic patients, are more exposed to hyperglycemia
and hyperinsulinemia states that can interfere with immune cell
functions including cytokines productions [16].2. Materials and methods
2.1. Subjects and Ala16Val–MnSOD polymorphism analysis
The research study is part of a project approved by the Ethics
Committee of the Universidade Federal de Santa Maria. All blood
cell donors signed a consent form. To perform this study we used
a similar methodology described in Montagner et al. [14] and Costa
et al. [17]. Brieﬂy, we selected 200 healthy adults without cardio-
vascular medical history, hypertension, obesity or other metabolic
diseases or morbidity that could affect the results. A DNA extrac-
tion was performed from the peripheral blood collection to per-
form the Ala16Val–MnSOD polymorphism genotyping using the
Polymerase Chain Reaction followed by the Restriction Fragment
Length Polymorphism (PCR-RFLP) techniques. From these volun-
teers, we also excluded those who were smokers, were using
chronic medication, vitamin supplements or taking hormonal con-
traceptives. Because Montano et al. [13] showed an association be-
tween the Ala16Val polymorphism and dietary behaviour, we
selected volunteers with similar lifestyle behaviours regarding diet
and physical activity to avoid possible environmental interfer-
ences. Additionally, we asked volunteers to avoid consuming anti-
oxidant-containing foods for 24 h before blood collection. The
foods that were not consumed by volunteers included salads, fruits
and juices. Three subjects of each genotype, who were considered
to have the ideal proﬁle, were selected as blood donors for the
in vitro assays performed in this study.2.2. PBMCs culture and treatments
PBMCs were obtained from the blood of the volunteers by cen-
trifugation with Ficoll–Histopaque to isolate the mononuclear
cells. The PBMCs were immediately transferred to culture tubes
at 5.0  104 cells concentration. RPMI 1640 supplemented with
10% fetal calf serum (FCS), PHA and 1% penicillin/streptomycin
was used added to the PBMCs culture medium. The PBMCs weremaintained in a suspended culture medium at 37 oC in a 5% humid-
iﬁed CO2 atmosphere for 72 h.
PBMCs carriers with different Ala16Val–MnSOD obtained from
these cultures were centrifuged for 10 min (3 rpm) and transferred
to tubes with an HBSS buffer containing 118 mMNaCl, 4.6 mM KCl,
10 mM D-glucose, 20 mM HEPES, 0.4 mM CaCl2, and pH 7.4. The
cells were washed twofold with an HBSS buffer and transferred
to the same buffer with and without glucose and insulin
supplementation.
The PBMCs with different genotypes were grouped in the follow
treatments: HBSS buffer only, containing 10 mM D-glucose (H);
HSBB enriched with an additional 5 mM glucose (G); HSBB en-
riched with 5 mU insulin (I) and ﬁnally, HSBB enriched with both
glucose (5 mM) and insulin (5 mM) (GI).
The PBMCs were maintained in these treatments for six hours.
Since the same number of cells was placed in each treatment and
we used a basic HSBB buffer as a medium to guarantee the survival
of cells, we assume that in the period of treatment the cellular pro-
liferation was low and cell viability was similar with minimal
interference on the results. We tested this assumption from the
lactate dehydrogenase enzyme evaluation measured by
spectrophotometry.
Additionally, we measured to discover if the glucose present in
the HSBB buffer was differentially used by PBMC Ala16Val–MnSOD
carriers. The glucose concentrations in the HSBB buffer medium
and in the PBMCs were evaluated by spectrophotometry assay
using a commercial kit (Glucose PAP Labtest, Lagoa Santa, Brazil).
The ﬁnal glucose level that indirectly indicates glucose utilization
from the medium buffer culture was calculated by subtracting
the glucose value obtained after six hours by the glucose measure
before the treatments exposition. The results were transformed by
percentage considering as 100% the glucose level found in basal
moment (0 h).
During a six hour period of treatments, we analysed the levels
of the proinﬂammatory cytokines interleukin 1 (IL-1), interleukin
6 (IL-6), tumor necrosis factor alpha (TNF-a), gamma interferon
(IFN-c) using the ELISA capture, according to the manufacturer’s
instructions (Biomyx Technology, San Diego, CA).2.3. Statistics analysis
All analyses were carried out using the SPSS statistical software,
version 18.0 (SPSS Inc., Chicago, IL). The results were presented in
mean ± standard deviation. The LDH, cytokine, as well as glucose
levels were compared among different PBMC Ala16Val–MnSOD
carriers with or without HSBB glucose and insulin, were compared
among genotypes using an analysis of two-way variance followed
by Tukey post hoc test. All p values were two-tailed. The alpha va-
lue considered to be statistically signiﬁcant was p = 0.05.3. Results and discussion
Initially, we sought to analyze LDH enzyme activity, to evaluate
the treatment’s effect on PBMCs viability. We found no difference
in the LDH levels among treatments before or after six hours
(LDL Mean in 0 h = 7.3 ± 1.0 U/l; LDL Mean in 6 h = 7.8 ± 1.7U/l).
Therefore, we assumed that the allotted time for treatment, as well
as the glucose and insulin supplementation added in HSBB med-
ium, did not induce a toxicity state.
The glucose level in the PBMCs carrier is different Ala16Val–
MnSOD genotypes with and without medium glucose and enriched
insulin were also measured (Fig. 1). The glucose levels were similar
among PBMCs carriers different from Ala16Val–MnSOD genotypes
in a medium without glucose and insulin supplementation. How-
ever in the presence of these molecules the percentage of glucose
Fig. 1. The percentage of glucose after a six-hour cell culture with and without
glucose and insulin supplementation of PBMCs carriers is different from the
Ala16Val SOD2 genotypes (AA, AV, VV). H = culture without glucose/insulin
supplementation; G = glucose supplementation (5 mM); I = insulin supplementa-
tion (5 mM), GI = glucose plus insulin supplementation. For each PBMCs genotype,
different letters (abc) indicate signiﬁcant differences at p > 0.001 from the analysis
of the variance followed by the Tukey post hoc test.
Table 1
Comparison of cytokines levels among peripheral blood mononuclear cells with
different Ala16Val-SOD2 genotypes.
Variables (pg/ml) Genotypes Mean ± SD
Interleukin 1 AA 23.9 ± 1.8a
VV 99.0 ± 2.0b
AV 55.9 ± 2.5c
Total 59.6 ± 32.7
Interleukin 6 AA 76.0 ± 2.1a
VV 122.7 ± 2.6b
AV 87.3 ± 2.5c
Total 95.3 ± 2.2
TNF-a AA 81.1 ± 3.0a
VV 148.3 ± 2.6b
AV 100.0 ± 2.0c
Total 99.9 ± 13.4
IFN-c AA 80.0 ± 2.0a
VV 199.9 ± 1.1b
AV 158.3±,2.5c
Total 146.0 ± 52.1
Interleukin 10 AA 55.6 ± 2.5a
VV 34.6 ± 2.5b
AV 46.7 ± 2.6c
Total 48.3 ± 10.6
AA, AV and AV = genotypes from Ala16Val SOD2 polymorphism; SD = standard
deviation; different letters (a, b, c) indicated signiﬁcant differences evaluated by
Anova One-way followed by Tukey post hoc test. P < 0.0001. Number of subjects
analyzed of each genotype: 03.
32 M.A.E. Montano et al. / Cytokine 60 (2012) 30–33after 6 h compared to basal glucose (0 h) was differentially
modiﬁed in the same ways as Ala16Val genotypes (p < 0.0001).
AA-PBMCs and VV-PBMCs presented higher glucose levels when
enriched with glucose than cells with and without insulin and
glucose plus insulin. Nevertheless, in the heterozygous PBMCs,
the glucose supplementation (with and without insulin) decreased
the percentage of glucose after 6 h.
Despite the methodological limitation in the glucose measure-
ment performed here by a spectrophotometry assay, our data sug-
gest that the PBMCs mitochondrial oxidative metabolism present
some regulation effect on energetic metabolism when more glu-
cose occurs and with more insulin availability to the cell. There
is a close relation between energetic metabolism that produces
ATP from glucose and oxygen and the production of ROS (superox-
ide ion) that is metabolized by the SOD2 enzyme. As the PBMCs did
not need to present GLUT receptors to obtain glucose of medium
we can postulated that the impairment in the SOD2 efﬁciency ob-
served in the V allele could to affect the glucose use for the cells.
However, the mechanism that this phenomenon occurs is an open
question.
The SOD2 is a key enzyme that protects the energy-generating
mitochondria from oxidative damage. Therefore, the potential
involvement of oxidative metabolism from differential SOD2 efﬁ-
ciency genetically determined on cell energetic metabolism cor-
roborate previous investigations that described effects of
nutritional status on mitochondrial physiology of PBMCs especially
lymphocytes [18,19]. These studies also consider that nutritional
diseases such as obesity, hyperglycaemia, and insulin resistance af-
fect directly the lymphocyte mitochondrial oxidative phosphoryla-
tion and other mitochondrial metabolic responses.
Our results also corroborate the potential involvement of Ala16-
Val SOD2 polymorphism on susceptibility risk to developed obes-
ity, diabetes and their metabolic alterations, like LDL oxidized
and triglycerides [11,13,20] and clinical complications as retinopa-
thy [10] previously described in the literature.
We also analyzed the potential effect of Ala16Val SOD2
polymorphism on the production of PBMCs cytokines involvingan inﬂammatory response. As seen in Table 1, the PBMCs carrier
VV genotype presented higher levels of proinﬂammatory cytokines
IL-1, IL-6, TNF-a, IFN-c the level of IL-10 antiinﬂammatory cyto-
kine was lower in these cells when compared to PBMCs carrier
AA genotype. The PBMCs carrier’s heterozygous genotypes pre-
sented intermediary cytokine values when compared to AA and
VV genotypes indicating the co-dominance nature of this genetic
trait on the cytokine levels measure here.
Superoxide anions have a proinﬂammatory role in many dis-
eases and past studies have reported that SOD2 has the potential
to be used as an antiinﬂammatory agent because of its superoxide
anion scavenging ability [21]. Our data corroborate the evidences
that the suppressive effects of SOD2 are related to inﬂammatory
diseases [15]. Therefore, subjects with less SOD2 efﬁciency might
present more susceptibility to establish the inﬂammatory process
related to the development and maintenance of diseases such as
obesity and diabetes. However, if the less efﬁciency of SOD2, genet-
ically determined by Ala16Val polymorphism presents potential
pharmacogenetic effects on the treatment response of inﬂamma-
tory diseases like obesity, it is an open question that needs to be
explored in future studies.Acknowledgments
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